Cargando…

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study

BACKGROUND: Deutetrabenazine is approved in the USA, China, Australia, Israel, Brazil, and South Korea for the treatment of chorea associated with Huntington disease. OBJECTIVE: We aimed to evaluate the long-term safety and tolerability of deutetrabenazine for the treatment of Huntington disease. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frank, Samuel, Testa, Claudia, Edmondson, Mary C., Goldstein, Jody, Kayson, Elise, Leavitt, Blair R., Oakes, David, O’Neill, Christine, Vaughan, Christina, Whaley, Jacquelyn, Gross, Nicholas, Gordon, Mark Forrest, Savola, Juha-Matti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653309/ https://www.ncbi.nlm.nih.gov/pubmed/36242718 http://dx.doi.org/10.1007/s40263-022-00956-8

Ejemplares similares

Review of deutetrabenazine: a novel treatment for chorea associated with Huntington’s disease
por: Dean, Marissa, et al.
Publicado: (2018)

Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect
por: Schneider, Frank, et al.
Publicado: (2020)

Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease
por: Claassen, Daniel O., et al.
Publicado: (2017)

Pharmacokinetic and Metabolic Profile of Deutetrabenazine (TEV‐50717) Compared With Tetrabenazine in Healthy Volunteers
por: Schneider, Frank, et al.
Publicado: (2020)

On crushing of deutetrabenazine tablets
por: Knebel, Helena, et al.
Publicado: (2021)

Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
por: Rodrigues, Filipe B., et al.
Publicado: (2017)

Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study
por: Hauser, Robert A., et al.
Publicado: (2022)

Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial
por: Jankovic, Joseph, et al.
Publicado: (2021)

Phenotype–genotype discrepancies in the prospective Huntington at‐risk observational study
por: Shoulson, Ira, et al.
Publicado: (2019)

Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial
por: Coffey, Barbara, et al.
Publicado: (2021)

Safety and Efficacy of Long‐Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open‐Label Extension Study
por: Jankovic, Joseph, et al.
Publicado: (2023)

The History of Huntington's Chorea
por: Stevens, David L.
Publicado: (1972)

Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis
por: Claassen, Daniel O., et al.
Publicado: (2021)

Upper facial chorea in Huntington disease
por: Fekete, Robert, et al.
Publicado: (2014)

Meta-research metrics matter: letter regarding article “indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease”
por: Rodrigues, Filipe B., et al.
Publicado: (2017)

Deutetrabenazine in Tics Associated with Tourette Syndrome
por: Jankovic, Joseph, et al.
Publicado: (2016)

The Prevention of Huntington's Chorea: The Milroy Lecture 1985
por: Harper, Peter S.
Publicado: (1986)

Benign Presentation Following Massive Deutetrabenazine Overdose
por: Obadeyi, Oluseyi, et al.
Publicado: (2021)

Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering
por: Ha, Catherine A., et al.
Publicado: (2021)

Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration‐QTc Analysis
por: Schneider, Frank, et al.
Publicado: (2022)

EPA and Huntington's chorea: treatment and associated cerebral changes
por: Puri, Basant K
Publicado: (2010)

Coexistence of Gait Disturbances and Chorea in Experimental Huntington's Disease
por: Casaca-Carreira, João, et al.
Publicado: (2015)

Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease
por: Coppen, Emma M., et al.
Publicado: (2016)

Chorea–Acanthocytosis and the Huntington Disease Allele in an Irish Family
por: Murphy, Olwen C., et al.
Publicado: (2018)

Update on the Non-Huntington's Disease Choreas with Comments on the Current Nomenclature
por: Walker, Ruth H.
Publicado: (2012)

Novel Imaging Biomarkers for Huntington’s Disease and Other Hereditary Choreas
por: Fazio, Patrik, et al.
Publicado: (2018)

Anti-ma2 receptor encephalitis mimicking Huntington chorea
por: Etemadifar, Masoud, et al.
Publicado: (2017)

Measurement of bradykinesia and chorea in Huntington's Disease using ambulatory monitoring
por: Kotschet, Katya, et al.
Publicado: (2022)

Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease
por: Cohen, Shani, et al.
Publicado: (2018)

A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
por: Patel, Rikinkumar S., et al.
Publicado: (2019)

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia
por: Fernandez, Hubert H, et al.
Publicado: (2019)

An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington’s Disease
por: Burgunder, Jean-Marc, et al.
Publicado: (2011)

Anesthetic management of a patient with Huntington's chorea -A case report-
por: Kang, Jong-Man, et al.
Publicado: (2013)

A Case of Huntington's Chorea: Sir Clifford Allbutt's Clinical Lecture
Publicado: (1918)

George Huntington: And His Relationship to the Earlier Descriptions of Chronic Hereditary Chorea
por: De Jong, Russell N.
Publicado: (1937)

Defining Utility Values for Chorea Health States in Patients with Huntington’s Disease
por: Claassen, Daniel O., et al.
Publicado: (2022)

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study
por: Fernandez, Hubert H., et al.
Publicado: (2017)

Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
por: Frank, Samuel
Publicado: (2010)

Differential Diagnosis of Chorea—HIV Infection Delays Diagnosis of Huntington’s Disease by Years
por: Achenbach, Jannis, et al.
Publicado: (2021)

Chorea me a river: depression in Huntington’s disease as an exemplar of precision medicine
por: Hannan, Anthony J
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rhv1tptmfisf8edrkt1gpb63k3